IL166513A0 - Lamellarin derivatives and pharmaceutical compositions containing the same - Google Patents

Lamellarin derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL166513A0
IL166513A0 IL16651305A IL16651305A IL166513A0 IL 166513 A0 IL166513 A0 IL 166513A0 IL 16651305 A IL16651305 A IL 16651305A IL 16651305 A IL16651305 A IL 16651305A IL 166513 A0 IL166513 A0 IL 166513A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
lamellarin
derivatives
Prior art date
Application number
IL16651305A
Other languages
English (en)
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Publication of IL166513A0 publication Critical patent/IL166513A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
IL16651305A 2002-08-13 2005-01-26 Lamellarin derivatives and pharmaceutical compositions containing the same IL166513A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0218816.7A GB0218816D0 (en) 2002-08-13 2002-08-13 Antitumoral analogs of lamellarins
PCT/GB2003/003541 WO2004014917A2 (en) 2002-08-13 2003-08-13 Antitumoral analogs of lamellarins

Publications (1)

Publication Number Publication Date
IL166513A0 true IL166513A0 (en) 2006-01-15

Family

ID=9942234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16651305A IL166513A0 (en) 2002-08-13 2005-01-26 Lamellarin derivatives and pharmaceutical compositions containing the same

Country Status (17)

Country Link
US (1) US7396837B2 (ru)
EP (2) EP1551844B1 (ru)
JP (1) JP2005536529A (ru)
KR (1) KR20050053613A (ru)
CN (2) CN1688585A (ru)
AT (1) ATE475663T1 (ru)
AU (1) AU2003252997B2 (ru)
CA (1) CA2493725A1 (ru)
DE (1) DE60333578D1 (ru)
GB (1) GB0218816D0 (ru)
HK (1) HK1078580A1 (ru)
IL (1) IL166513A0 (ru)
MX (1) MXPA05001731A (ru)
NO (1) NO20051282L (ru)
NZ (1) NZ537935A (ru)
RU (1) RU2328500C2 (ru)
WO (1) WO2004014917A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071587B2 (en) 2009-05-27 2011-12-06 N. V. Organon (Dihydro)imidazoiso[5,1-A]quinolines
TW201116531A (en) 2009-07-29 2011-05-16 Organon Nv Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
US8431564B2 (en) 2009-07-29 2013-04-30 Merck Sharp & Dohme B.V. Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
WO2011035417A1 (en) * 2009-09-25 2011-03-31 Aegera Therapeutics Inc. Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases
WO2012099129A1 (ja) * 2011-01-17 2012-07-26 国立大学法人 長崎大学 抗癌活性化合物
WO2012126084A1 (en) * 2011-03-24 2012-09-27 Pharmascience Inc. Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
KR101721029B1 (ko) * 2014-10-16 2017-03-29 연세대학교 산학협력단 인돌리지노[3,2-c]퀴놀린 유도체, 이의 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 낭포성 섬유증 예방 또는 치료용 약학조성물
TWI674265B (zh) * 2017-03-27 2019-10-11 東海大學 片螺素及其衍生物之製造方法
CN110461850B (zh) * 2017-03-29 2022-10-18 国立大学法人长崎大学 第四代egfr酪氨酸激酶抑制剂
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112300232B (zh) * 2020-11-03 2021-11-09 浙江大学 Lamellarin D糖基化衍生物及其制备和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
AUPO656597A0 (en) * 1997-05-02 1997-05-29 Australian National University, The Preparation of therapeutic compounds
AUPP433398A0 (en) 1998-06-25 1998-07-16 Australian National University, The Compounds and processes

Also Published As

Publication number Publication date
NZ537935A (en) 2007-02-23
WO2004014917A3 (en) 2004-05-13
JP2005536529A (ja) 2005-12-02
RU2328500C2 (ru) 2008-07-10
ATE475663T1 (de) 2010-08-15
US7396837B2 (en) 2008-07-08
MXPA05001731A (es) 2005-08-16
EP2138496A1 (en) 2009-12-30
AU2003252997B2 (en) 2009-08-06
NO20051282L (no) 2005-05-11
DE60333578D1 (de) 2010-09-09
WO2004014917A2 (en) 2004-02-19
CA2493725A1 (en) 2004-02-19
CN101941977A (zh) 2011-01-12
AU2003252997A1 (en) 2004-02-25
EP1551844B1 (en) 2010-07-28
RU2005106863A (ru) 2005-11-10
CN1688585A (zh) 2005-10-26
US20060173030A1 (en) 2006-08-03
HK1078580A1 (en) 2006-03-17
GB0218816D0 (en) 2002-09-18
EP1551844A2 (en) 2005-07-13
KR20050053613A (ko) 2005-06-08

Similar Documents

Publication Publication Date Title
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
DE69831868D1 (en) Antithrombosemittel
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
AUPR213700A0 (en) Antiviral agents
GB9914486D0 (en) Medicaments
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
CA2510853A1 (en) Pyrrolopyrimidine derivatives
IL133623A0 (en) Antithrombotic agents
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
CA2373117A1 (en) 13-methyl-erythromycin derivatives
EP2269608A3 (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
WO2006042954A8 (fr) Dérivés de 2-amido-4-phenylthiazole, leur préparation et leur application en thérapeutique
DE602004011966D1 (en) Heterocyclylverbindungen
AU2001286768A1 (en) Novel macrocycles and uses thereof
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
PT992509E (pt) Novos derivados macrolidos
GEP20074127B (en) Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
WO2004014389A8 (en) 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
DE60114640D1 (en) Antithrombosemittel
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
EP1404652A4 (en) NEW ALKALOID DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
EP1434762A4 (en) 4'-METHANSULFONYLBIPHENYL DERIVATIVES AS HIGH-DETECTIVE CYCLOOXYGENASE-2 INHIBITORS
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
TW200510370A (en) Urea derivatives